Price to Sales ratio Analysis of Novavax Inc - Deep Dive
Latest FY PS
Period Ending - Dec-23
Good PS
1.54
Period Ending - Dec-22
Very Good PS
0.593
Growth
159.67 %
Trailing Twelve Months PS
Period Ending - Dec-23
Indecisive PS
1.83
PS Analysis of Novavax Inc
PS Ratio of NVAX rose handsomely by 159.67 % this year. |
PS Ratio with value of 19.41 was highest in Year Dec-19 in last Five Years. |
PS Ratio with value of 0.593 was lowest in Year Dec-22 in last Five Years. |
Latest PS Ratio with value of 1.54 is lower than Average PS of 4.87 in last five years. |
Other PS Related Info of NVAX that may interest you.
Novavax Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
NVAX | 15.03 | 15.25 | 1.44 % | Biotechnology |
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions. more ..PS Related Ratios
PriceToBookRatio | PriceToEarningRatio | AssetTurnoverRatio |
Tsr Value Index
Very Low Value Stock |
FY - Historical Price to Sales of Novavax Inc
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
---|---|---|---|---|---|---|---|
PS | 1.54 | 0.593 | 0.976 | 1.82 | 19.41 | 0.405 | 0.353 |
Change | 159.67 % | -39.22 % | -46.37 % | -90.63 % | 4690.10 % | 14.87 % | -46.78 % |
FY Chart of Price to Sales of Novavax Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)